3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...

3/31/2025Roche's Ocrevus Receives Chinese Approval for MS

3/31/2025Bio-Thera and Dr. Reddy's Execute Commercialization Deal for BAT2206 a...

3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib

3/28/2025Eisai to Divest China Rights for Pariet® to Peak Pharma

3/28/2025DualityBio Advances Toward Hong Kong Stock Exchange Listing

3/28/2025Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...

3/28/2025GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...

3/28/2025Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...

3/28/2025AstraZeneca Advances AZD0120 CAR-T Trial for Lupus

3/28/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...

3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...

3/28/2025Recent Executive Moves

3/28/2025China Releases Draft Implementation Measures for the Protection of Dru...

3/27/2025Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)

3/27/2025China to Spur Innovation through New Reimbursement List (ThePharmaLett...

3/27/2025China Poised to Surpass Europe in Pharma Innovation, Says AZ CEO

3/27/2025China Faces Ongoing TB Prevention Challenges Despite Declining Inciden...

3/27/2025NMPA Approves Suraxavir Marboxil for Influenza Treatment

3/26/2025Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346

3/26/2025Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...

3/26/2025NMPA Holds 2025 National Drug Regulatory Policy and Law Conference

3/26/2025NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...

3/26/2025Bayer Secures Global Rights to Puhe BioPharma's Experimental Cancer Dr...

3/26/2025Life Science Ecosystems in Asia: Biomedical Innovation Trends over the...

3/25/2025Anda Biopharma Secures Series A Funding to Advance PCNAT-01 Clinical S...

3/25/2025Novo Nordisk and the United Labs Announce License Deal for UBT251

3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...

3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...

3/25/2025Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...

Page:32/789 Total number of articles:23668: [First][<<] [30] [31] [32] [33] [34] [>>] [End]